Literature DB >> 19224870

Weighing harm in therapeutic decisions of smear-negative pulmonary tuberculosis.

Juan Moreira1, Bettina Bisig, Petronille Muwawenimana, Paulin Basinga, Zeno Bisoffi, Frank Haegeman, Panduru Kishore, Jef Van den Ende.   

Abstract

PURPOSE: To relate the intuitive weight of harm by commission and harm by omission in therapeutic decisions for pulmonary tuberculosis, and to compare it with a weight based on probabilities.
METHODS: Clinicians were asked for an estimation of probabilities related with the outcome of treated and nontreated pulmonary tuberculosis and for the toll of wrong decisions. Three ratios of the weight of forgoing a treatment in false-negative patients against the weight of treating false-positives were calculated. The first was based on intuitive estimations, whereas the second and third were based on calculated, either through intuitive estimations of probabilities or through literature data. The association between experience and the difference between the intuitive and the calculated ratios was assessed.
RESULTS: Eighty-one participants from Ecuador, Laos, Nepal, and Rwanda responded. The ratio of intuitive weights was 2.0 (interquartile range [IQR], 1.0-4.0) and the ratio of calculated weights based on intuitive probabilities was 64 (IQR, 25.0-169.6; P < 0.001). The ratio of calculated weight based on literature probabilities was 30 (IQR, 17.9-59.2). No association (R(2) = 0.03) was found between experience and accuracy in estimating the weight of errors.
CONCLUSION: The weight of a false negative is more important than the weight of a false positive for therapeutic decisions in pulmonary tuberculosis. The ratio of the intuitively estimated weights was much lower than the calculation based on intuitively estimated influencing factors. Clinicians were accurate in estimating probabilities but failed to incorporate them into therapeutic decisions.

Entities:  

Mesh:

Year:  2009        PMID: 19224870     DOI: 10.1177/0272989X08327330

Source DB:  PubMed          Journal:  Med Decis Making        ISSN: 0272-989X            Impact factor:   2.583


  8 in total

Review 1.  A scoping review of unintended harm associated with public health interventions: towards a typology and an understanding of underlying factors.

Authors:  L K Allen-Scott; J M Hatfield; L McIntyre
Journal:  Int J Public Health       Date:  2014-01-01       Impact factor: 3.380

2.  Is scale-up worth it? Challenges in economic analysis of diagnostic tests for tuberculosis.

Authors:  David W Dowdy; Adithya Cattamanchi; Karen R Steingart; Madhukar Pai
Journal:  PLoS Med       Date:  2011-07-26       Impact factor: 11.069

3.  Is increasing complexity of algorithms the price for higher accuracy? virtual comparison of three algorithms for tertiary level management of chronic cough in people living with HIV in a low-income country.

Authors:  Constance Mukabatsinda; Jasmine Nguyen; Bettina Bisig; Lutgarde Lynen; Yerma D Coppens; Anita Asiimwe; Jef Van den Ende
Journal:  BMC Med Inform Decis Mak       Date:  2012-01-19       Impact factor: 2.796

4.  What if They Don't Have Tuberculosis? The Consequences and Trade-offs Involved in False-positive Diagnoses of Tuberculosis.

Authors:  Rein M G J Houben; Marek Lalli; Katharina Kranzer; Nick A Menzies; Samuel G Schumacher; David W Dowdy
Journal:  Clin Infect Dis       Date:  2019-01-01       Impact factor: 9.079

5.  Sensitivity and specificity of tuberculosis signs and symptoms screening and adjunct role of social pathology characteristics in predicting bacteriologically confirmed tuberculosis in Myanmar.

Authors:  Kyaw Ko Ko Htet; Virasakdi Chongsuvivatwong; Si Thu Aung
Journal:  Trop Med Health       Date:  2021-01-07

6.  Intuitive weights of harm for therapeutic decision making in smear-negative pulmonary Tuberculosis: an interview study of physicians in India, Pakistan and Bangladesh.

Authors:  Chandrashekhar T Sreeramareddy; Mahbubur Rahman; H N Harsha Kumar; Mohsin Shah; Ahmed Manadir Hossain; Md Abu Sayem; Juan M Moreira; Jef Van den Ende
Journal:  BMC Med Inform Decis Mak       Date:  2014-08-08       Impact factor: 2.796

7.  Estimated clinical impact of the Xpert MTB/RIF Ultra cartridge for diagnosis of pulmonary tuberculosis: A modeling study.

Authors:  Emily A Kendall; Samuel G Schumacher; Claudia M Denkinger; David W Dowdy
Journal:  PLoS Med       Date:  2017-12-14       Impact factor: 11.069

8.  Rationality, practice variation and person-centred health policy: a threshold hypothesis.

Authors:  Benjamin Djulbegovic; Robert M Hamm; Thomas Mayrhofer; Iztok Hozo; Jef Van den Ende
Journal:  J Eval Clin Pract       Date:  2015-12-07       Impact factor: 2.431

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.